期刊文献+

超声及其钙化特征对桥本甲状腺炎背景下甲状腺乳头状癌的诊断结果分析 被引量:5

Diagnosis of Thyroid Papillary Carcinoma in the Background of Hashimoto's Thyroiditis by Ultrasound and Its Calcification
下载PDF
导出
摘要 目的:探析超声钙化特征对HT(桥本甲状腺炎)背景下甲状腺乳头状癌(Thyroid papillary carcinoma,TPC)的诊断结果。方法:参研对象选取2014年8月~2017年8月本院收治的200例甲状腺结节患者,对其临床资料予以回顾性分析,其中合并HT者100例(甲组)与非HT者100例(乙组),参照病理结果,对比超声钙化征象对两组的诊断结果。结果:甲组诊断准确率为77%,乙组为81%,P>0.05,无统计学意义;甲组恶性结节微钙化与粗钙化率为51.4%,5.4%,乙组依次为50%,11.8%,组间比较差异小,P>0.05,不具有统计学意义;甲组、乙组并恶性结节微钙化的占比与良性结节相比均有明显差异,P<0.05,存在统计学意义;甲组恶性结节并粗钙化的占比与良性结节伴粗钙化的占比比较差异性小,P>0.05,不具有临床可比性,但乙组上述指标相比则有显著差异,P<0.05,统计学意义成立。结论:超声及其钙化特征对HT背景下TPC性质的诊断影响不明显。
作者 张平 余龙会 ZHANG Ping;YU Long-hui(Department of Ultrasound, Qujing First People?s Hospital of Yunnan Province (Yunnan Qujing 655000)
出处 《中国医疗器械信息》 2018年第9期74-75,共2页 China Medical Device Information
  • 相关文献

参考文献5

二级参考文献54

  • 1Asai, Satomi,Miyachi, Hayato,Suzuki, Kaori,Shimamura, Kazuo,Ando, Yasuhiko.Ultrasonographic differentiation between tuberculous lymphadenitis and malignant lymph nodes. Journal of Ultrasound in Medicine . 2001
  • 2Jill E. Langer,Susan J. Mandel.Sonographic Imaging of Cervical Lymph Nodes in Patients with Thyroid Cancer[J]. Neuroimaging Clinics of North America . 2008 (3)
  • 3A. I. Backer,K. J. Mortelé,E. Heuvel,I. J. Vanschoubroeck,M. M. Kockx,M. Vyvere.Tuberculous adenitis: comparison of CT and MRI findings with histopathological features[J]. European Radiology . 2007 (4)
  • 4Robbins K T,Medina J E,Wolfe G T,Levine P A,Sessions R B,Pruet C W.Standardizing neck dissection terminology. Official report of the Academy’s Committee for Head and Neck Surgery and Oncology. Archives of otolaryngology--head & neck surgery . 1991
  • 5Dudea Sorin M,Lenghel Manuela,Botar-Jid Carolina,Vasilescu Dan,Duma Magdalena.Ultrasonography of superficial lymph nodes: benign vs. malignant. Medical ultrasonography . 2012
  • 6郭慧菲,薛恩生,林礼务,等.甲状腺滤泡状癌超声表现与鉴别[J].中华医学超声杂志,2013,10(2):106-109.
  • 7Cantwell-Dorris ER, O' leary JJ, Sheils OM. BRAFV600E: im- plications for carcinogenesis and molecular therapy [ J ]. Mol Cancer Ther, 2011, 10(3) : 385 -394.
  • 8Palona I, Namba H, Mitsutake N, et al. BRAFv6E promotes in- vasiveness of thyroid cancer ceils through nuclear factor kappaB activation [ J]. Endocrinology, 2006, 147 (12) : 5699 - 5707.
  • 9Xing M, Westra WH, Tufano RP, et al. BRAF mutation predictsa poorer clinical prognosis for papillary thyroid cancer [J]. J Clin Endocrinol Metab, 2005, 90( 12): 6373-6379.
  • 10Caronia LM, Phay JE, Shah MH. Role ot BHAI' in thyrmd onco- genesis [J]. Clin Cancer Res, 2011, 17(24) : 7511 -7517.

共引文献44

同被引文献63

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部